Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
MINNEAPOLIS, March 29, 2016 -- 21st North Inc. (formerly known as Urologix, Inc.) announced today that its Special Meeting of Shareholders commenced earlier today was adjourned for lack of quorum and will be reconvened at 10:00 a.m. local time on April 25, 2016. The reconvened meeting will be held at 4200 IDS Center, 80 South 8th Street, Minneapolis, Minnesota 55402. Extending the voting until April 25th, 2016 provides additional time for shareholders to submit their proxy cards. Shareholders that have voted do not need to vote again.
The Special Meeting of Shareholders is for the purpose of approving the dissolution of 21st North Inc. pursuant to the Plan of Dissolution previously distributed to shareholders. 21st North Inc. has no assets, no operations and substantial liabilities in the form of debt owed to a secured creditor following surrender of the assets to its creditor and subsequent asset sale to a private buyer effective on January 29, 2016. There will be no shareholder distributions nor any transfer of value or liabilities to shareholders as a result of this transaction. Shareholder approval of the Plan of Dissolution will enable the company to terminate the legal existence of the shell in an orderly manner.
Contact Information: Greg Fluet [email protected]
